{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T12:43:12Z","timestamp":1774183392039,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Knights Templar Eye Foundation,United States"},{"name":"Chakraborty Family Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00741-4","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:15:58Z","timestamp":1754630158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune landscape in children with X-linked retinoschisis"],"prefix":"10.1186","volume":"26","author":[{"given":"Ying","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Del","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Lobeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei I.","family":"Syrbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sinkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"Fortenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene V.","family":"Drack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"11","key":"741_CR1","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.1074\/jbc.M413117200","volume":"280","author":"WW Wu","year":"2005","unstructured":"Wu WW, Wong JP, Kast J, Molday RS. RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer. J Biol Chem. 2005;280(11):10721\u201330.","journal-title":"J Biol Chem"},{"issue":"3","key":"741_CR2","first-page":"816","volume":"42","author":"LL Molday","year":"2001","unstructured":"Molday LL, Hicks D, Sauer CG, Weber BH, Molday RS. Expression of X-linked retinoschisis protein RS1 in photoreceptor and bipolar cells. Invest Ophthalmol Vis Sci. 2001;42(3):816\u201325.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"741_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ophtha.2021.09.021","volume":"129","author":"LC Hahn","year":"2022","unstructured":"Hahn LC, van Schooneveld MJ, Wesseling NL, Florijn RJ, Ten Brink JB, Lissenberg-Witte BI, et al. X-Linked retinoschisis: novel clinical observations and genetic spectrum in 340 patients. Ophthalmology. 2022;129(2):191\u2013202.","journal-title":"Ophthalmology"},{"issue":"7","key":"741_CR4","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1172\/JCI81380","volume":"125","author":"JX Ou","year":"2015","unstructured":"Ou JX, Vijayasarathy C, Ziccardi L, Chen S, Zeng Y, Marangoni D, et al. Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-transfer. J Clin Invest. 2015;125(7):2891\u2013903.","journal-title":"J Clin Invest"},{"issue":"9","key":"741_CR5","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1167\/iovs.04-0576","volume":"45","author":"Y Zeng","year":"2004","unstructured":"Zeng Y, Takada Y, Kjellstrom S, Hiriyanna K, Tanikawa A, Wawrousek E, et al. RS-1 gene delivery to an adult Rs1h knockout mouse model restores ERG b-wave with reversal of the electronegative waveform of X-linked retinoschisis. Invest Ophthalmol Vis Sci. 2004;45(9):3279\u201385.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"741_CR6","doi-asserted-by":"crossref","unstructured":"Vijayasarathy C, Zeng Y, Marangoni D, Dong LJ, Pan ZH, Simpson EM et al. Targeted expression of retinoschisin by retinal bipolar cells in XLRS promotes resolution of retinoschisis cysts Sans RS1 from photoreceptors. Invest Ophthalmol Vis Sci. 2022;63(11): 1-11.","DOI":"10.1167\/iovs.63.11.8"},{"key":"741_CR7","doi-asserted-by":"publisher","first-page":"1304819","DOI":"10.3389\/fmed.2024.1304819","volume":"11","author":"S Hassan","year":"2024","unstructured":"Hassan S, Hsu Y, Thompson JM, Kalmanek E, VandeLune JA, Stanley S, et al. The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-hRS1 in a mouse model of X-linked retinoschisis. Front Med (Lausanne). 2024;11:1304819.","journal-title":"Front Med (Lausanne)"},{"key":"741_CR8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/OPTH.S364200","volume":"16","author":"HH Ghoraba","year":"2022","unstructured":"Ghoraba HH, Akhavanrezayat A, Karaca I, Yavari N, Lajevardi S, Hwang J, et al. Ocular gene therapy: A literature review with special focus on immune and inflammatory responses. Clin Ophthalmol. 2022;16:1753\u201371.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"741_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","volume":"26","author":"G Le Meur","year":"2018","unstructured":"Le Meur G, Lebranchu P, Billaud F, Adjali O, Schmitt S, Bezieau S, et al. Safety and Long-Term efficacy of AAV4 gene therapy in patients with RPE65 leber congenital amaurosis. Mol Ther. 2018;26(1):256\u201368.","journal-title":"Mol Ther"},{"issue":"9","key":"741_CR10","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","volume":"26","author":"C Cukras","year":"2018","unstructured":"Cukras C, Wiley HE, Jeffrey BG, Sen HN, Turriff A, Zeng Y, et al. Retinal AAV8-RS1 gene therapy for X-Linked retinoschisis: initial findings from a phase i\/iia trial by intravitreal delivery. Mol Ther. 2018;26(9):2282\u201394.","journal-title":"Mol Ther"},{"issue":"12","key":"741_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.oret.2022.06.013","volume":"6","author":"ME Pennesi","year":"2022","unstructured":"Pennesi ME, Yang P, Birch DG, Weng CY, Moore AT, Iannaccone A, et al. Intravitreal delivery of rAAV2tYF-CB-hRS1 vector for gene augmentation therapy in patients with X-Linked retinoschisis: 1-Year clinical results. Ophthalmol Retina. 2022;6(12):1130\u201344.","journal-title":"Ophthalmol Retina"},{"key":"741_CR12","doi-asserted-by":"publisher","first-page":"676046","DOI":"10.3389\/fimmu.2021.676046","volume":"12","author":"L Zhu","year":"2021","unstructured":"Zhu L, Chen B, Su W. A review of the various roles and participation levels of B-Cells in Non-Infectious uveitis. Front Immunol. 2021;12:676046.","journal-title":"Front Immunol"},{"issue":"1","key":"741_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","volume":"19","author":"P Fitzgerald-Bocarsly","year":"2008","unstructured":"Fitzgerald-Bocarsly P, Dai JH, Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008;19(1):3\u201319.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"741_CR14","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.ymthe.2021.02.013","volume":"29","author":"A Mishra","year":"2021","unstructured":"Mishra A, Vijayasarathy C, Cukras CA, Wiley HE, Sen HN, Zeng Y, et al. Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase i\/iia gene therapy trial. Mol Ther. 2021;29(6):2030\u201340.","journal-title":"Mol Ther"},{"issue":"30","key":"741_CR15","doi-asserted-by":"publisher","first-page":"28139","DOI":"10.1074\/jbc.M302464200","volume":"278","author":"WW Wu","year":"2003","unstructured":"Wu WW, Molday RS. Defective discoidin domain structure, subunit assembly, and Endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis. J Biol Chem. 2003;278(30):28139\u201346.","journal-title":"J Biol Chem"},{"issue":"22","key":"741_CR16","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1016\/j.visres.2006.06.011","volume":"46","author":"A Iannaccone","year":"2006","unstructured":"Iannaccone A, Mura M, Dyka FM, Ciccarelli ML, Yashar BM, Ayyagari R, et al. An unusual X-linked retinoschisis phenotype and biochemical characterization of the W112C mutation. Vis Res. 2006;46(22):3845\u201352.","journal-title":"Vis Res"},{"issue":"7","key":"741_CR17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/hmg\/ddq006","volume":"19","author":"YV Sergeev","year":"2010","unstructured":"Sergeev YV, Caruso RC, Meltzer MR, Smaoui N, MacDonald IM, Sieving PA. Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis. Hum Mol Genet. 2010;19(7):1302\u201313.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"741_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/bjo.2005.078048","volume":"90","author":"T Wang","year":"2006","unstructured":"Wang T, Zhou A, Waters CT, O\u2019Connor E, Read RJ, Trump D. Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation. Br J Ophthalmol. 2006;90(1):81\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"741_CR19","doi-asserted-by":"publisher","first-page":"e82586","DOI":"10.1371\/journal.pone.0082586","volume":"8","author":"W Li","year":"2013","unstructured":"Li W, Okuda A, Yamamoto H, Yamanishi K, Terada N, Yamanishi H, et al. Regulation of development of CD56 bright CD11c\u2009+\u2009NK-like cells with helper function by IL-18. PLoS ONE. 2013;8(12):e82586.","journal-title":"PLoS ONE"},{"issue":"6","key":"741_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/1074-7613(94)90093-0","volume":"1","author":"J Pugin","year":"1994","unstructured":"Pugin J, Heumann D, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. Cd14 is a Pattern-Recognition receptor. Immunity. 1994;1(6):509\u201316.","journal-title":"Immunity"},{"issue":"5","key":"741_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/80833","volume":"1","author":"EA Kurt-Jones","year":"2000","unstructured":"Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1(5):398\u2013401.","journal-title":"Nat Immunol"},{"issue":"12","key":"741_CR22","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1084\/jem.20101111","volume":"207","author":"CL Baumann","year":"2010","unstructured":"Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bl\u00fcml S, Grebien F, et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med. 2010;207(12):2689\u2013701.","journal-title":"J Exp Med"},{"key":"741_CR23","doi-asserted-by":"publisher","first-page":"34310","DOI":"10.1038\/srep34310","volume":"6","author":"WH Yeap","year":"2016","unstructured":"Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310.","journal-title":"Sci Rep"},{"issue":"16","key":"741_CR24","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, et al. Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113(16):3716\u201325.","journal-title":"Blood"},{"issue":"4","key":"741_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4\u2009<\u2009SUP>+\u2009CD25\u2009<\u2009SUP>+\u2009regulatory T cells. Nat Immunol. 2003;4(4):330\u20136.","journal-title":"Nat Immunol"},{"issue":"6","key":"741_CR26","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","volume":"35","author":"N Yu","year":"2012","unstructured":"Yu N, Li X, Song W, Li D, Yu D, Zeng X, et al. CD4(+)CD25 (+)CD127 (low\/-) T cells: a more specific Treg population in human peripheral blood. Inflammation. 2012;35(6):1773\u201380.","journal-title":"Inflammation"},{"issue":"1","key":"741_CR27","doi-asserted-by":"publisher","first-page":"2381261","DOI":"10.1080\/19420862.2024.2381261","volume":"16","author":"B Liao","year":"2024","unstructured":"Liao B, Tumanut C, Li L, Corper A, Challa D, Chang A, et al. Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers. MAbs. 2024;16(1):2381261.","journal-title":"MAbs"},{"issue":"2","key":"741_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4049\/jimmunol.1701128","volume":"200","author":"AR Victor","year":"2018","unstructured":"Victor AR, Weigel C, Scoville SD, Chan WK, Chatman K, Nemer MM, et al. Epigenetic and posttranscriptional regulation of CD16 expression during human NK cell development. J Immunol. 2018;200(2):565\u201372.","journal-title":"J Immunol"},{"issue":"10","key":"741_CR29","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.4049\/jimmunol.143.10.3283","volume":"143","author":"P Selvaraj","year":"1989","unstructured":"Selvaraj P, Carpen O, Hibbs ML, Springer TA. Natural killer cell and granulocyte Fc-Gamma receptor Iii (Cd16) differ in membrane anchor and signal transduction. J Immunol. 1989;143(10):3283\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"741_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/imm.13464","volume":"166","author":"K Roe","year":"2022","unstructured":"Roe K. NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion-the differences and similarities. Immunology. 2022;166(2):155\u201368.","journal-title":"Immunology"},{"issue":"2","key":"741_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2249.2010.04169.x","volume":"161","author":"RJ Harrison","year":"2010","unstructured":"Harrison RJ, Ettorre A, Little AM, Khakoo SI. Association of NKG2A with treatment for chronic hepatitis C virus infection. Clin Exp Immunol. 2010;161(2):306\u201314.","journal-title":"Clin Exp Immunol"},{"key":"741_CR32","first-page":"17","volume":"16","author":"EI Obeagu","year":"2024","unstructured":"Obeagu EI. Immunological equilibrium: unpacking CD4\/CD8 ratios in HIV. Infection. 2024;16:17.","journal-title":"Infection"},{"issue":"9","key":"741_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/23744235.2020.1778178","volume":"52","author":"C Pallotto","year":"2020","unstructured":"Pallotto C, Suardi LR, Esperti S, Tarquini R, Grifoni E, Meini S, et al. Increased CD4\/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study. Infect Dis (Lond). 2020;52(9):675\u20137.","journal-title":"Infect Dis (Lond)"},{"issue":"3\u20134","key":"741_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1359-6101(03)00024-8","volume":"14","author":"GA Bishop","year":"2003","unstructured":"Bishop GA, Hostager BS. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 2003;14(3\u20134):297\u2013309.","journal-title":"Cytokine Growth Factor Rev"},{"key":"741_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","volume":"72","author":"MF Alejandro Aruffo","year":"1993","unstructured":"Alejandro Aruffo MF, Diane Hollenbaugh X, Li A, Milatovich S, Nonoyama J, Bajorath LS, Grosmaire R, Stenkamp M, Neubauer RL, Robert, Randolph J, Noelle JA, Ledbetter. Uta francke, Hans D. Ochs. The CD40 ligand, gp39, is defective in activated T celts from patients with X-Linked Hyper-IgM syndrome. Cell. 1993;72:291\u2013300.","journal-title":"Cell"},{"issue":"2","key":"741_CR36","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1038\/cti.2016.2","volume":"5","author":"JR Smith","year":"2016","unstructured":"Smith JR, Stempel AJ, Bharadwaj A, Appukuttan B. Involvement of B cells in non-infectious uveitis. Clin Transl Immunol. 2016;5(2):e63.","journal-title":"Clin Transl Immunol"},{"issue":"4","key":"741_CR37","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/jcmm.13019","volume":"21","author":"K Plossl","year":"2017","unstructured":"Plossl K, Weber BH, Friedrich U. The X-linked juvenile retinoschisis protein retinoschisin is a novel regulator of mitogen-activated protein kinase signalling and apoptosis in the retina. J Cell Mol Med. 2017;21(4):768\u201380.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"741_CR38","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1111\/1759-7714.14471","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Cheng G, Chen P, Peng Y, Liu L, Li R, et al. RS1 gene is a novel prognostic biomarker for lung adenocarcinoma. Thorac Cancer. 2022;13(12):1850\u201361.","journal-title":"Thorac Cancer"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00741-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00741-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00741-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:20:46Z","timestamp":1757355646000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00741-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00741-4","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in accordance with Declaration of Helsinki and with IRB #201911037 approved by the Institutional Review Board at the University of Iowa. Informed consent was obtained from the parents or guardian. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}